Hizentra has a long half-life of roughly 40 days, meaning it takes several months to fully clear from your system after you stop treatment. Because it’s a concentrated form of IgG antibodies, your body processes it the same way it handles its own natural antibodies, breaking it down slowly over time rather than eliminating it quickly like most medications.
Half-Life and Clearance Timeline
The half-life of IgG delivered through Hizentra is approximately 40 days. That means every 40 days or so, your body eliminates about half of the dose still circulating. Using this timeline, it takes roughly five to six half-lives for a substance to be considered effectively cleared, which puts full elimination somewhere around 200 to 240 days (about 7 to 8 months) after your last dose.
This is significantly longer than most prescription drugs, which clear in hours or days. The reason is that Hizentra isn’t a small chemical molecule. It’s purified human immunoglobulin G, a large protein that your body treats as its own. Your cells actively work to keep it around rather than flush it out.
Why Your Body Holds Onto It So Long
Your cells contain a specialized receptor that acts like a recycling system for IgG antibodies. When cells absorb proteins from the surrounding fluid, IgG binds to this receptor inside small compartments called endosomes, where conditions are slightly acidic. Instead of being sent to the cell’s waste disposal system, the IgG is shuttled back to the cell surface and released into the bloodstream at neutral pH. This recycling loop is the reason IgG antibodies last so much longer than other types of proteins your body produces. Without it, the half-life would be a fraction of what it is.
Hizentra’s IgG takes advantage of this same recycling pathway. Once the antibodies absorb from the injection site into your blood and lymphatic system, they’re protected by the same mechanism that preserves your body’s own antibodies.
How Dosing Frequency Affects Drug Levels
Most people take Hizentra weekly, but some use it on a biweekly schedule. The dosing frequency changes how much your levels fluctuate between doses but doesn’t significantly change overall drug exposure. In clinical studies, mean trough levels were nearly identical between weekly and biweekly dosing (10.21 and 10.13 g/dL, respectively) when the total monthly dose was kept the same.
With weekly dosing, IgG levels in your blood peak about 2.9 days after injection on average, though this varies widely from person to person (anywhere from the same day to a full 7 days). The difference between your highest and lowest levels during a week is relatively small. In the FDA’s pivotal study, mean peak levels were 1,616 mg/dL and mean trough levels were 1,448 mg/dL, a fluctuation of only about 10%. This is one of the advantages of subcutaneous immunoglobulin over intravenous infusions, which produce much larger swings.
With biweekly dosing, peak levels are slightly higher because you’re getting a double-sized dose, but trough levels stay comparable. Some patients show a small dip in IgG around day 4 (for weekly dosing) or day 6 (for biweekly dosing) before levels rise again, creating a subtle double-peak pattern.
How Long to Rebuild Levels After a Gap
If you miss one or more doses, your IgG levels will gradually drift downward. When you restart, it takes approximately 5 to 6 weeks for trough levels to climb back to their previous steady state. This timeline is worth knowing because it means a short gap in treatment doesn’t leave you immediately unprotected, but it also means you can’t quickly “catch up” with a single large dose. The long half-life works both ways: levels fall slowly when you stop and rebuild slowly when you restart.
Factors That Speed Up or Slow Down Clearance
Not everyone clears Hizentra at the same rate. In clinical trials, apparent clearance ranged from 1.2 to 3.7 mL/day/kg in adults, a threefold difference between the fastest and slowest eliminators. Several things influence where you fall on that spectrum.
Body composition matters. The antibodies are injected into subcutaneous tissue, and from there they drain into the lymphatic system before reaching the bloodstream. Factors like hydration, the amount of adipose tissue at the injection site, and even physical activity level all affect how quickly the drug absorbs and moves through the lymphatic system. People with more subcutaneous fat may experience slower absorption from the injection site.
Certain medical conditions accelerate IgG loss. Protein-losing conditions affecting the gut or kidneys can cause your body to shed antibodies faster than normal, shortening the effective duration of each dose. In these situations, clearance rates sit at the higher end of the range, and doses often need to be adjusted upward to maintain protective levels.
Children and adolescents show clearance rates similar to adults on a weight-adjusted basis (mean of 2.23 mL/day/kg in pediatric studies), so age alone doesn’t dramatically change how long the drug stays in the system.
What This Means Practically
If you’re wondering about Hizentra in the context of switching treatments, planning a medical procedure, or understanding a gap in therapy, the key numbers to keep in mind are: a half-life around 40 days, a return to steady state in 5 to 6 weeks after restarting, and full clearance over roughly 7 to 8 months after stopping entirely. Your IgG levels won’t drop to zero overnight if you miss a dose, but they also won’t bounce back instantly. The long, stable presence of the drug in your system is by design, since the goal is to maintain a consistent floor of protective antibodies rather than producing sharp peaks and valleys.